Please login to the form below

Not currently logged in
Email:
Password:

investment

This page shows the latest investment news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Novartis exists anti-infectives drive, Hancock takes over from Hunt and Trump attacks 'soft Brexit' plan

Daily Brief: Novartis exists anti-infectives drive, Hancock takes over from Hunt and Trump attacks 'soft Brexit' plan

FDA Commissioner Scott Gottlieb published proposals to entice industry investment in antibiotic R&D last month, while the EU and WHO are also funding collaborative initiatives. ... investment into the EU.

Latest news

  • Abingworth raises $315m to expand hunt for promising biotechs Abingworth raises $315m to expand hunt for promising biotechs

    UK investment group Abingworth has raised $315m for its latest fund ABV VII, overshooting its $300m target, and indicating that the appetite for biotech investment remains strong. ... the firm which has seen 65 of its investments go onto public offerings

  • VC raises new €270m fund for European biotechs VC raises new €270m fund for European biotechs

    Life sciences venture capital company Forbion has raised 270m in funding for European biotechs, in a sign that investment cash is returning to the sector. ... Forbion’s fundraising comes shortly after UK- and US-based VC Abingworth raised $315m for

  • Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’ Vertex to Theresa May: Orkambi verdict ‘threatens bio investment

    Vertex to Theresa May: Orkambi verdict ‘ threatens bio investment’. CEO writes open letter to prime minister. ... These policy statements and plans must translate to improved patient access to innovative therapies, ”it says in the letter, adding:

  • Malthus’ orphans Malthus’ orphans

    If so, the projections on which orphan drug investments are premised may prove optimistic.

  • Healthcare Comms news Healthcare Comms news

    Ewbank said: “Our new office represents a significant investment in our international operations, providing opportunities for our people and clients to meet in a professional yet collaborative environment.

More from news
Approximately 16 fully matching, plus 1,065 partially matching documents found.

Latest Intelligence

  • Developing advocacy in the pharmaceutical industry Developing advocacy in the pharmaceutical industry

    measures to which other investments would be subject. ... When it comes to advocacy, return on investment is perhaps not so straightforward, but there are some metrics – both qualitative and quantitative – that can be applied.

  • Got marketing ambition? You need to master biases of cognition Got marketing ambition? You need to master biases of cognition

    Such an example is that of irrational escalation: the observation that individuals or groups – even when faced with increasingly negative outcomes from some decision, action or investment – continue the same behaviour

  • 30 Women Leaders in UK Healthcare (part 2)

    ecosystem. In her 25-plus years in the sector, her investments have resulted in the launch of six drugs, spanning inflammatory and autoimmune disease and cancer. ... the UK’s new Dementia Discovery Fund (DDF) and serves on the DDF Investment Committee.

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    She also decided to pay $13bn to buy Novartis out of the companies’consumer health joint venture, a tricky balancing act to pull off when also looking to increase investment in

  • Reaching the new influencers Reaching the new influencers

    But the nature of these interactions has changed. Complexity of therapies, regulations, transparency, digital and the need to be versed in economic benefit requires new skill sets, capabilities, investments and commitments

More from intelligence
Approximately 3 fully matching, plus 240 partially matching documents found.

Latest appointments

  • Industry round up: appointments Industry round up: appointments

    Rodgers, who has gained board experience in both public and private growth companies, has a background in the financial sector as a corporate financier and investment banker.

  • Weekly comms appointments Weekly comms appointments

    This appointment signifies the start of a serious investment period as we plan for growth around a global client base increasingly involved in developing breakthrough technologies in healthcare.”.

  • Lars Rebien Sørensen becomes chairman of Novo Holdings Lars Rebien Sørensen becomes chairman of Novo Holdings

    He said: “In recent years, Novo Holdings has significantly increased its investments and influence in the global life science sector. ... I consider it to be a great responsibility to lead the continued growth of Novo Holdings as it plans to further

  • Open Health creates new role Open Health creates new role

    be representing Open Health in this important investment.”.

  • Matt de Gruchy to lead PR agency Reynolds Mackenzie Matt de Gruchy to lead PR agency Reynolds Mackenzie

    We must continue with this excellence, but also look to evolve and grow our offer through investment in our digital/social offer and an increasing profile in global comms among other

More from appointments
Approximately 0 fully matching, plus 91 partially matching documents found.

Latest from PMHub

  • Training the next generation of biotech leaders

    The UK’ s key competitors in Europe and the US are storming ahead in this field, funnelling investment into manufacturing innovations. ... This will mean investment in process analytic technologies and methods for monitoring and controlling the cell

  • SWITCHED ONcology

    The campaign provides our partners with deeper insight, smarter ideas and more meaningful innovations, born out of an unprecedented investment into oncology.

  • Wearables and Healthcare

    In order to leverage health benefit through full integration into the healthcare system, significant investment in time, technology, systems, awareness campaigns, education and training will be necessary over the coming years.

  • Why patient education isn’t simple

    Taking a longer-term view, increased investment of time and quality of communication with patients leads to much less investment in time and resources later down the line, ultimately resulting in

  • Beyond the event

    Who just joined?”. There's no substitute for face-to-face meetings. But meetings require a significant investment, with often substantial venue and travel costs, as well as the opportunity costs ... Therefore, it's vital for meeting owners to maximise

More from PMHub
Approximately 2 fully matching, plus 146 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics